Tag Archives: M42’s Danat Al Emarat Hospital

Health Care

M42’s Danat Al Emarat Hospital pioneers immunotherapy for Type 1 diabetes treatment in the region

  • Danat Al Emarat Hospital for Women & Children demonstrates success in using Teplizumab for Type 1 diabetes treatment in the UAE and wider region
  • Teplizumab is an immunotherapy drug designed to delay the onset of Type 1 diabetes (T1D) in those  who have a confirmed diagnosis of T1D without clinical symptoms, as determined through the assessment of beta-cell function
  • It is one of the biggest treatment breakthroughs for the chronic condition since the discovery of insulin more than 100 years ago
Continue reading M42’s Danat Al Emarat Hospital pioneers immunotherapy for Type 1 diabetes treatment in the region →
Health Care

Scientific papers on Obstetrics and Gynecology by M42’s Danat Al Emarat Hospital recognized for their contribution to women’s health at RCOG World Congress

  • Scientific papers on Obstetrics and Gynecology were selected and presented at the 2024 edition of the Royal College of Obstetricians and Gynaecologists (RCOG) World Congress in Oman
  • Both papers were among the 500 chosen from a total of 10,000 submissions worldwide for publication in the highly renowned British Journal of Obstetrics and Gynecology’s forthcoming issue

Abu Dhabi, United Arab Emirates; October 24, 2024: M42’s Danat Al Emarat Hospital for Women & Children announces that its scientific studies in Obstetrics and Gynecology for advancing birthing techniques and postpartum best practices were selected and presented at the Royal College of Obstetricians and Gynaecologists (RCOG) World Congress. Selected from a total number of 10,000 submissions, the scientific papers will be published in the upcoming issue of British Journal of Obstetrics and Gynecology (BJOG Journal).

Continue reading Scientific papers on Obstetrics and Gynecology by M42’s Danat Al Emarat Hospital recognized for their contribution to women’s health at RCOG World Congress →